TY  - JOUR

T1  - Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence between 2018-2022

JO  - Value in Health

UR  - https://doi.org/10.1016/j.jval.2024.11.013

PY  - 2024/12/24

AU  - Gibbons CL

AU  - Latimer NR

ED  - 

DO  - DOI: 10.1016/j.jval.2024.11.013

PB  - Elsevier BV

Y2  - 2025/02/13

ER  -